Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer.
Abrahamova J, Wagnerova M, Kubala E, Malec V, Simova E, Sirakova I, Pavlikova E, Machova D, Kocak I, Pavlikova I, Tuma P, Prausova J, Kroslakova D, Van Praagh I.
Abrahamova J, et al. Among authors: wagnerova m.
Oncologist. 2001;6(4):347-52. doi: 10.1634/theoncologist.6-4-347.
Oncologist. 2001.
PMID: 11524553
Free article.
Clinical Trial.